V-Echinocandin (VEC): Began Phase III trial

Versicor Inc. (VERS), Fremont, Calif. Product: V-Echinocandin (VEC) Business: Infectious diseases Therapeutic category: Bacterial replication Target: Cell wall synthesis enzyme Description: Inhibitor...